Transcripta Bio
AI Healthcare
Drug discovery / transcriptomics
Series A
Transcripta Bio is a privately held biotechnology company in the AI healthcare/drug discovery space that uses transcriptomics and artificial intelligence to map disease signatures, match drugs to cellular profiles, and accelerate therapeutic development. The company focuses on serious diseases, including neurological and neuromuscular indications, and describes its platform as a closed-loop discovery engine built on transcriptomic signature matching.
Company Details
- Website
- transcriptabio.com
- Headquarters
- Palo Alto, California, United States
- Founded
- 2020
- Funding
- $32.6M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring